0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-08-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 02104545 2023-08-01 2024-07-31 02104545 2024-07-31 02104545 2023-07-31 02104545 2022-08-01 2023-07-31 02104545 2023-07-31 02104545 2022-07-31 02104545 bus:Director1 2023-08-01 2024-07-31 02104545 core:WithinOneYear 2024-07-31 02104545 core:WithinOneYear 2023-07-31 02104545 core:AfterOneYear 2024-07-31 02104545 core:AfterOneYear 2023-07-31 02104545 core:ShareCapital 2024-07-31 02104545 core:ShareCapital 2023-07-31 02104545 core:RetainedEarningsAccumulatedLosses 2024-07-31 02104545 core:RetainedEarningsAccumulatedLosses 2023-07-31 02104545 bus:Director1 2023-07-31 02104545 bus:Director1 2024-07-31 02104545 bus:Director1 2022-07-31 02104545 bus:Director1 2023-07-31 02104545 bus:SmallEntities 2023-08-01 2024-07-31 02104545 bus:AuditExemptWithAccountantsReport 2023-08-01 2024-07-31 02104545 bus:SmallCompaniesRegimeForAccounts 2023-08-01 2024-07-31 02104545 bus:PrivateLimitedCompanyLtd 2023-08-01 2024-07-31 02104545 bus:AbridgedAccounts 2023-08-01 2024-07-31 02104545 core:OtherRelatedParties 2024-07-31 02104545 core:OtherRelatedParties 2023-08-01 2024-07-31
COMPANY REGISTRATION NUMBER: 02104545
UK Medi Care Enterprise Limited
Filleted Unaudited Abridged Financial Statements
For the year ended
31 July 2024
UK Medi Care Enterprise Limited
Abridged Statement of Financial Position
31 July 2024
2024
2023
Note
£
£
£
Current assets
Cash at bank and in hand
1,579
1,029
Creditors: amounts falling due within one year
420
420
-------
-------
Net current assets
1,159
609
-------
----
Total assets less current liabilities
1,159
609
Creditors: amounts falling due after more than one year
124,494
123,414
----------
----------
Net liabilities
( 123,335)
( 122,805)
----------
----------
Capital and reserves
Called up share capital
100
100
Profit and loss account
( 123,435)
( 122,905)
----------
----------
Shareholders deficit
( 123,335)
( 122,805)
----------
----------
These abridged financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of income and retained earnings has not been delivered.
For the year ending 31 July 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its abridged financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements .
All of the members have consented to the preparation of the abridged statement of income and retained earnings and the abridged statement of financial position for the year ending 31 July 2024 in accordance with Section 444(2A) of the Companies Act 2006.
UK Medi Care Enterprise Limited
Abridged Statement of Financial Position (continued)
31 July 2024
These abridged financial statements were approved by the board of directors and authorised for issue on 2 April 2025 , and are signed on behalf of the board by:
Dr S George
Director
Company registration number: 02104545
UK Medi Care Enterprise Limited
Notes to the Abridged Financial Statements
Year ended 31 July 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 132 Burnt Ash Road, Lee, London, SE12 8PU.
2. Statement of compliance
These abridged financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The abridged financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The abridged financial statements are prepared in sterling, which is the functional currency of the entity.
Income tax
Provision is made, under the liability method, to take account of timing differences between the treatment of certain items for accounts purposes and their treatment for tax purposes. Tax deferred or accelerated is accounted for in respect of all material timing differences to the extent that it is considered that a net liability may arise.
Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.
4. Directors' advances, credits and guarantees
During the year the directors entered into the following advances and credits with the company:
2024
Balance brought forward
Advances/ (credits) to the directors
Balance outstanding
£
£
£
Dr S George
( 123,414)
( 1,080)
( 124,494)
----------
-------
----------
2023
Balance brought forward
Advances/ (credits) to the directors
Balance outstanding
£
£
£
Dr S George
( 123,414)
( 123,414)
----------
----
----------
5. Related party transactions
Included in creditors falling due in more than one year is an amount of £ 124,494 (2023:£123,414) owing to directors . The directors have stated that these loans are not due for repayment in the foreseeable future.